-
Mashup Score: 0
Background: Low-dose aspirin lowers cardiovascular event risk; dual-pathway inhibition (DPI) using low-dose aspirin with low-dose rivaroxaban may reduce this risk
Source: www.ecrjournal.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 14
Lingering cardiac symptoms are increasingly recognised complications of severe acute respiratory syndrome coronavirus 2 infection, now referred to as post-acute cardiovascular sequelae of
Source: www.ecrjournal.comCategories: General Medicine News, Cardiologists1Tweet
-
Mashup Score: 4
The expansion of the therapeutic armamentarium available to oncologists and haematologists has led to a significant improvement in cancer survival; however, many of the available treatments carry
Source: www.ecrjournal.comCategories: General Medicine News, Partners & KOLsTweet-
🎗️We're marking #WorldCancerDay by celebrating all the fantastic research in #CardioOnc! Access key articles: 2022 European Society of Cardiology Cardio-oncology Guidelines in Focus 👉 https://t.co/0TUd6xL8IH Ventricular Arrhythmia in Cancer Patients 👉 https://t.co/spxJH4tXA3 https://t.co/Gb6N3rYq4w
-
-
Mashup Score: 15Alcohol and Heart Failure - 4 month(s) ago
Alcohol is the most frequently consumed toxic substance in the world and remains a major global public health issue, with one in three adults consuming it
Source: www.ecrjournal.comCategories: General Medicine News, Expert PicksTweet
-
Mashup Score: 15Alcohol and Heart Failure - 4 month(s) ago
Alcohol is the most frequently consumed toxic substance in the world and remains a major global public health issue, with one in three adults consuming it
Source: www.ecrjournal.comCategories: General Medicine News, Expert PicksTweet
-
Mashup Score: 3Evidence-based Management of Left Main Coronary Artery Disease - 4 month(s) ago
Left main coronary artery disease (LMCAD) is associated with high morbidity and mortality due to the large myocardial mass at risk. Although medical treatment may be an option in selected
Source: www.ecrjournal.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 7EASD 23: Efinopegdutide in NAFLD & Type 2 Diabetes Patients - 6 month(s) ago
EASD 2023 — In this short interview, Dr Samuel S Engel (Associate Vice President at Merck) discusses a study investigating the effectiveness and safety of efinopegdutide (MK-6024) in patients
Source: www.ecrjournal.comCategories: General Medicine News, Partners & KOLsTweet-
🩸Today is #WorldDiabetesDay Discover key studies and trials within the landscape in these 2 insightful videos. Dr Samuel S Engel discusses a study into the effectiveness and safety of #efinopegdutide in patients with #NAFLD and type 2 diabetes 👉 https://t.co/mL26e2D8YR Dr… https://t.co/tGg5edumzc https://t.co/MIPtlGTgMx
-
-
Mashup Score: 2Validating the Prognostic Utility of the ABCD-GENE Score in Asian Patients with Acute Coronary Syndrome Patients on Clopidogrel - 6 month(s) ago
Background: The ABCD-GENE score, which links cytochrome P450 2C19 (CYP2C19) phenotype and high platelet reactivity (HPR) to the risk of major adverse cardiovascular events (MACE) in
Source: www.ecrjournal.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 0Decreased Noise and Identification of Very Low Voltage Signals Using a Novel Electrophysiology Recording System - 6 month(s) ago
Aims: The interpretation of intracardiac electrograms recorded from conventional electrophysiology recording systems is frequently impacted by powerline (50/60 Hz) noise and distortion due to
Source: www.ecrjournal.comCategories: General Medicine News, Partners & KOLsTweet-
📚New #ECRJournal Article📚 📊This study compares unipolar #EGM recordings from a conventional EP system and one of two 3D mapping systems with those from a novel system (ECGenius, CathVision ApS) designed to reduce noise without conventional filtering 👉 https://t.co/V5EejPTXku https://t.co/F4smkvmUEM
-
-
Mashup Score: 1Current Volume | ECR Journal - 6 month(s) ago
ECR – Volume 18, 2023 Prof Juan Carlos Kaski, Dr Pablo Avanzas and the Editorial Board are pleased to present Volume 18 of European Cardiology Review. The editorial team hopes you find this volume valuable in your clinical practice. European Cardiology Review is always seeking submissions from leading figures from across the community. A 30% discount on article processing charges is…
Source: www.ecrjournal.comCategories: General Medicine News, Partners & KOLsTweet
📚New #ECRJournal Article: "Dual-pathway Inhibition versus Aspirin Monotherapy" 📚 Just Published! 🔓Access it here 👉 https://t.co/elUfLTwn5C @dirksibbing #Anticoagulation #MedEd #CardioEd https://t.co/PMzWZvm7tx